Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Kenya's High Court halted a U.S. plan to establish a quarantine facility for Americans exposed to Ebola, delaying a $...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
A Capitol Hill hearing pits growth-focused remedies against traditional funding gaps for Social Security, with the na...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...
Trump hints at government equity in AI leaders, echoing Bernie Sanders and roiling MAGA voters as markets weigh how A...
Blackstone's flagship private-credit fund drew heavier redemptions than typical, underscoring strain in private credi...
An elderly shopper nearly wired $7,000 in bitcoin to a scammer posing as Apple Support. A vigilant gas station clerk ...
Europe is poised to become a leader in trusted, industrialized AI as regulators push for guardrails and firms invest ...
Public accountability stories grab headlines and shake confidence. This guide explains how such moments can affect yo...
A fast-moving shift in AI could turn cyber threats into a global financial crisis if firms don’t act. This article br...
A 58-year-old divorcée with $1.4 million from a QDRO cannot roll the funds into an IRA until a long-ago court order i...